Trial Profile
Additional effects of pioglitazone on type 2 diabetes who were inappropriately controlled with insulin therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2011
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms ACTION-J
- 11 Dec 2009 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 26 Aug 2009 New trial record